In: Archives of Gynecology and Obstetrics, 2015, vol. 291, no. 6, p. 1387-1394
|
In: Biology of Reproduction, 2017, vol. 97, no. 2, p. 197-216
|
In: Annals of Surgical Oncology, 2015, vol. 22, no. 13, p. 4198-4203
|
In: Breast Cancer Research and Treatment, 2015, vol. 150, no. 2, p. 363-371
|
In: Human Reproduction, 2018, vol. 33, no. 8, p. 1459-1465
|
In: Virchows Archiv, 2015, vol. 466, no. 6, p. 703-710
|
In: Journal of Molecular Cell Biology, 2016, vol. 8, no. 2, p. 157-173
|
In: Journal of the Endocrine Society, 2018, vol. 2, no. 4, p. 386-390
|
In: Annals of Surgical Oncology, 2015, vol. 22, p. 959-963
|
In: Molecular oncology, 2017, vol. 11, p. 781–791
It was already in the 18th century when the French surgeon LeDran first noted that breast cancer patients with spread of tumor cells to their axillary lymph nodes had a drastically worse prognosis than patients without spread (LeDran et al., ). Since then, metastatic spread of cancer cells to regional lymph nodes has been established as the most important prognostic factor in many types of...
|